世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035680

乳がん治療薬の世界市場(2023-2027)

TechNavio

Global Breast Cancer Therapeutics Market 2023-2027

発刊日 2023/06/02

言語英語

体裁PDF/161ページ

ライセンス/価格161ページ

0000035680

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

乳がん治療薬市場は、2022年から2027年の間に130億2,739万米ドル成長し、予測期間中に8.23 %のCAGRで加速すると予測されています。乳がん治療薬市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題に加えて、約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。乳がん罹患率の上昇、充実したパイプラインと新薬承認、患者支援イニシアチブの増加などが市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ 疾患タイプ別
      ◇ 浸潤性乳がん
      ◇ 非浸潤性乳管がん
    ➣ 製品別
      ◇ 標的療法
      ◇ ホルモン療法
      ◇ 化学療法
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

本調査では、今後数年間の乳がん治療薬市場の成長を促進する主な理由の1つとして、新たな新規治療法を挙げています。また、改善された診断モダリティの利用可能性と戦略的提携の増加は、市場の大規模な需要につながるでしょう。

乳がん治療薬市場に関するレポートは、次の分野をカバーしています。

  • 乳がん治療薬市場の規模
  • 乳がん治療薬市場の予測
  • 乳がん治療薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。また、乳がん治療薬市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

  • 調査企業
    ➣ AbbVie Inc.
    ➣ Amgen Inc.
    ➣ AstraZeneca
    ➣ Bristol Myers Squibb
    ➣ Clovis Oncology
    ➣ 第一三共(Daiichi Sankyo Co. Ltd.)
    ➣ エーザイ(Eisai Co. Ltd.)
    ➣ Eli Lilly and Co.
    ➣ Exelixis Inc.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ GlaxoSmithKline Plc
    ➣ Merck and Co. Inc.
    ➣ NanoString Technologies Inc.
    ➣ Novartis AG
    ➣ Perkin Elmer Inc.
    ➣ Pfizer Inc.
    ➣ Puma Biotechnology Inc.
    ➣ Sanofi
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Viatris Inc.

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global breast cancer therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global breast cancer therapeutics market 2017 - 2021 ($ million)
4.2 Disease type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Disease type Segment 2017 - 2021 ($ million)
4.3 Therapy Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Disease Type
6.1 Market segments
Exhibit 30: Chart on Disease Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Disease Type - Market share 2022-2027 (%)
6.2 Comparison by Disease Type
Exhibit 32: Chart on Comparison by Disease Type
Exhibit 33: Data Table on Comparison by Disease Type
6.3 Invasive breast cancers - Market size and forecast 2022-2027
Exhibit 34: Chart on Invasive breast cancers - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Invasive breast cancers - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Invasive breast cancers - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Invasive breast cancers - Year-over-year growth 2022-2027 (%)
6.4 Ductal carcinoma in situ - Market size and forecast 2022-2027
Exhibit 38: Chart on Ductal carcinoma in situ - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Ductal carcinoma in situ - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Ductal carcinoma in situ - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Ductal carcinoma in situ - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Disease Type
Exhibit 42: Market opportunity by Disease Type ($ million)
Exhibit 43: Data Table on Market opportunity by Disease Type ($ million)

7 Market Segmentation by Therapy
7.1 Market segments
Exhibit 44: Chart on Therapy - Market share 2022-2027 (%)
Exhibit 45: Data Table on Therapy - Market share 2022-2027 (%)
7.2 Comparison by Therapy
Exhibit 46: Chart on Comparison by Therapy
Exhibit 47: Data Table on Comparison by Therapy
7.3 Targeted therapy - Market size and forecast 2022-2027
Exhibit 48: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
7.4 Hormonal therapy - Market size and forecast 2022-2027
Exhibit 52: Chart on Hormonal therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Hormonal therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Hormonal therapy - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Hormonal therapy - Year-over-year growth 2022-2027 (%)
7.5 Chemotherapy - Market size and forecast 2022-2027
Exhibit 56: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Therapy
Exhibit 60: Market opportunity by Therapy ($ million)
Exhibit 61: Data Table on Market opportunity by Therapy ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 Canada - Market size and forecast 2022-2027
Exhibit 91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 111: AbbVie Inc. - Overview
Exhibit 112: AbbVie Inc. - Product / Service
Exhibit 113: AbbVie Inc. - Key news
Exhibit 114: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 115: Amgen Inc. - Overview
Exhibit 116: Amgen Inc. - Product / Service
Exhibit 117: Amgen Inc. - Key offerings
12.5 AstraZeneca
Exhibit 118: AstraZeneca - Overview
Exhibit 119: AstraZeneca - Product / Service
Exhibit 120: AstraZeneca - Key news
Exhibit 121: AstraZeneca - Key offerings
12.6 Bristol Myers Squibb
Exhibit 122: Bristol Myers Squibb - Overview
Exhibit 123: Bristol Myers Squibb - Product / Service
Exhibit 124: Bristol Myers Squibb - Key news
Exhibit 125: Bristol Myers Squibb - Key offerings
12.7 Clovis Oncology
Exhibit 126: Clovis Oncology - Overview
Exhibit 127: Clovis Oncology - Business segments
Exhibit 128: Clovis Oncology - Key offerings
Exhibit 129: Clovis Oncology - Segment focus
12.8 Daiichi Sankyo Co. Ltd.
Exhibit 130: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 131: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibit 132: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 133: Daiichi Sankyo Co. Ltd. - Key offerings
12.9 Eli Lilly and Co.
Exhibit 134: Eli Lilly and Co. - Overview
Exhibit 135: Eli Lilly and Co. - Product / Service
Exhibit 136: Eli Lilly and Co. - Key news
Exhibit 137: Eli Lilly and Co. - Key offerings
12.10 Exelixis Inc.
Exhibit 138: Exelixis Inc. - Overview
Exhibit 139: Exelixis Inc. - Product / Service
Exhibit 140: Exelixis Inc. - Key offerings
12.11 F. Hoffmann La Roche Ltd.
Exhibit 141: F. Hoffmann La Roche Ltd. - Overview
Exhibit 142: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 143: F. Hoffmann La Roche Ltd. - Key news
Exhibit 144: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 145: F. Hoffmann La Roche Ltd. - Segment focus
12.12 GlaxoSmithKline Plc
Exhibit 146: GlaxoSmithKline Plc - Overview
Exhibit 147: GlaxoSmithKline Plc - Business segments
Exhibit 148: GlaxoSmithKline Plc - Key news
Exhibit 149: GlaxoSmithKline Plc - Key offerings
Exhibit 150: GlaxoSmithKline Plc - Segment focus
12.13 Merck and Co. Inc.
Exhibit 151: Merck and Co. Inc. - Overview
Exhibit 152: Merck and Co. Inc. - Business segments
Exhibit 153: Merck and Co. Inc. - Key news
Exhibit 154: Merck and Co. Inc. - Key offerings
Exhibit 155: Merck and Co. Inc. - Segment focus
12.14 NanoString Technologies Inc.
Exhibit 156: NanoString Technologies Inc. - Overview
Exhibit 157: NanoString Technologies Inc. - Product / Service
Exhibit 158: NanoString Technologies Inc. - Key offerings
12.15 Novartis AG
Exhibit 159: Novartis AG - Overview
Exhibit 160: Novartis AG - Business segments
Exhibit 161: Novartis AG - Key offerings
Exhibit 162: Novartis AG - Segment focus
12.16 Perkin Elmer Inc.
Exhibit 163: Perkin Elmer Inc. - Overview
Exhibit 164: Perkin Elmer Inc. - Business segments
Exhibit 165: Perkin Elmer Inc. - Key news
Exhibit 166: Perkin Elmer Inc. - Key offerings
Exhibit 167: Perkin Elmer Inc. - Segment focus
12.17 Pfizer Inc.
Exhibit 168: Pfizer Inc. - Overview
Exhibit 169: Pfizer Inc. - Product / Service
Exhibit 170: Pfizer Inc. - Key news
Exhibit 171: Pfizer Inc. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 172: Inclusions checklist
Exhibit 173: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 174: Currency conversion rates for US$
13.4 Research methodology
Exhibit 175: Research methodology
Exhibit 176: Validation techniques employed for market sizing
Exhibit 177: Information sources
13.5 List of abbreviations
Exhibit 178: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global breast cancer therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Disease type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Disease Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Disease Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Disease Type
Exhibits33: Data Table on Comparison by Disease Type
Exhibits34: Chart on Invasive breast cancers - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Invasive breast cancers - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Invasive breast cancers - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Invasive breast cancers - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Ductal carcinoma in situ - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Ductal carcinoma in situ - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Ductal carcinoma in situ - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Ductal carcinoma in situ - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Disease Type ($ million)
Exhibits43: Data Table on Market opportunity by Disease Type ($ million)
Exhibits44: Chart on Therapy - Market share 2022-2027 (%)
Exhibits45: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Therapy
Exhibits47: Data Table on Comparison by Therapy
Exhibits48: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Hormonal therapy - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Hormonal therapy - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Hormonal therapy - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Hormonal therapy - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Therapy ($ million)
Exhibits61: Data Table on Market opportunity by Therapy ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AbbVie Inc. - Overview
Exhibits112: AbbVie Inc. - Product / Service
Exhibits113: AbbVie Inc. - Key news
Exhibits114: AbbVie Inc. - Key offerings
Exhibits115: Amgen Inc. - Overview
Exhibits116: Amgen Inc. - Product / Service
Exhibits117: Amgen Inc. - Key offerings
Exhibits118: AstraZeneca - Overview
Exhibits119: AstraZeneca - Product / Service
Exhibits120: AstraZeneca - Key news
Exhibits121: AstraZeneca - Key offerings
Exhibits122: Bristol Myers Squibb - Overview
Exhibits123: Bristol Myers Squibb - Product / Service
Exhibits124: Bristol Myers Squibb - Key news
Exhibits125: Bristol Myers Squibb - Key offerings
Exhibits126: Clovis Oncology - Overview
Exhibits127: Clovis Oncology - Business segments
Exhibits128: Clovis Oncology - Key offerings
Exhibits129: Clovis Oncology - Segment focus
Exhibits130: Daiichi Sankyo Co. Ltd. - Overview
Exhibits131: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits132: Daiichi Sankyo Co. Ltd. - Key news
Exhibits133: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits134: Eli Lilly and Co. - Overview
Exhibits135: Eli Lilly and Co. - Product / Service
Exhibits136: Eli Lilly and Co. - Key news
Exhibits137: Eli Lilly and Co. - Key offerings
Exhibits138: Exelixis Inc. - Overview
Exhibits139: Exelixis Inc. - Product / Service
Exhibits140: Exelixis Inc. - Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. - Overview
Exhibits142: F. Hoffmann La Roche Ltd. - Business segments
Exhibits143: F. Hoffmann La Roche Ltd. - Key news
Exhibits144: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits145: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits146: GlaxoSmithKline Plc - Overview
Exhibits147: GlaxoSmithKline Plc - Business segments
Exhibits148: GlaxoSmithKline Plc - Key news
Exhibits149: GlaxoSmithKline Plc - Key offerings
Exhibits150: GlaxoSmithKline Plc - Segment focus
Exhibits151: Merck and Co. Inc. - Overview
Exhibits152: Merck and Co. Inc. - Business segments
Exhibits153: Merck and Co. Inc. - Key news
Exhibits154: Merck and Co. Inc. - Key offerings
Exhibits155: Merck and Co. Inc. - Segment focus
Exhibits156: NanoString Technologies Inc. - Overview
Exhibits157: NanoString Technologies Inc. - Product / Service
Exhibits158: NanoString Technologies Inc. - Key offerings
Exhibits159: Novartis AG - Overview
Exhibits160: Novartis AG - Business segments
Exhibits161: Novartis AG - Key offerings
Exhibits162: Novartis AG - Segment focus
Exhibits163: Perkin Elmer Inc. - Overview
Exhibits164: Perkin Elmer Inc. - Business segments
Exhibits165: Perkin Elmer Inc. - Key news
Exhibits166: Perkin Elmer Inc. - Key offerings
Exhibits167: Perkin Elmer Inc. - Segment focus
Exhibits168: Pfizer Inc. - Overview
Exhibits169: Pfizer Inc. - Product / Service
Exhibits170: Pfizer Inc. - Key news
Exhibits171: Pfizer Inc. - Key offerings
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Validation techniques employed for market sizing
Exhibits177: Information sources
Exhibits178: List of abbreviations

この商品のレポートナンバー

0000035680

TOP